Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Midgut Neuroendocrine Tumors × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Multiple Endocrine Neoplasia Type 1 96 Pituitary Neoplasms 55 Neuroendocrine Tumors 50 Thyroid Cancer, Papillary 41 Thyroid Neoplasms 16 Obesity 15 Pheochromocytoma 14 Overweight 11 Adrenal Gland Neoplasms 10 Weight Loss 9 Paraganglioma 9 Carcinoma, Neuroendocrine 9 Pancreatic Neoplasms 8 Prostatic Neoplasms 7 Motor Activity 7 Insulinoma 7 Gastrointestinal Neoplasms 7 Adrenocortical Adenoma 7 Acquired Immunodeficiency Syndrome 7 Neoplasm Metastasis 6 Hyperaldosteronism 6 Carcinoma, Medullary 6 Brain Neoplasms 6 Stomach Neoplasms 5 Osteoporosis 5 Neoplasms 5 Meningioma 5 Liver Neoplasms 5 Insulin Resistance 5 HIV Infections 5

Interventions

Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03667092 2025-04-10

GENEBIOLuNET

University Hospital, Toulouse

Phase NA Completed

Midgut Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡